Efficacy and Safety of Teicoplanin in CDAD
-
- STATUS
- Recruiting
-
- participants needed
- 50
-
- sponsor
- Sanofi
Summary
Primary Objective:
Explore the efficacy of
Secondary Objective:
Evaluate the safety of
Description
Approximate 10 weeks
Details
| Condition |
|
|---|---|
| Age | 18years - 100years |
| Treatment |
|
| Clinical Study Identifier | NCT04003818 |
| Sponsor | Sanofi |
| Last Modified on | 19 February 2024 |
How to participate?
,
Select a site
Enter your location to find study centers near you
study centers available
Send a message
Enter your contact details to connect with study team
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy AnnotationsStudy Notes
Enable the functional cookies in order to view/reply the sharedadd your annotations.
Add a private note
- Select a piece of text from the left.
- Add notes visible only to you.
- Send it to people through a passcode protected link.
Publish Annotation
Are you sure you want to publish the annotation?
Delete AnnotationNote
Are you sure you want to delete the annotationnote?
Study Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.